• Corpus ID: 8283986

Clinical Investigation of Levisticum officinale ( Lovage ) Effectiveness ’ in Patients with

  title={Clinical Investigation of Levisticum officinale ( Lovage ) Effectiveness ’ in Patients with},
  author={MehrdadMohammadi and Erfan Parvaneh and Zahra Tolou\_Ghamari},
Objective: According to previous publications, the erratic hereditary disease with the augmented urinary excretion of cystine, could be envisage as the key to major injury in complicated patients due to recurrent of kidney stones. Therefore, the aim of this study was to investigate the safety and efficacy of Levisticum officinale (Lovage) in patients with cystinuria Patients and methods: Patients with cystinuria (n=18), comprised of 10 males and 8 females was studied. The extract of Levisticum… 

Figures and Tables from this paper

Reducing urinary oxalate by simultaneous using Sankol herbal drop with oxalate-degrading bacteria
This is the first study on the simultaneous use of Sankol herbal drop and oxalate-degrading probiotic bacteria that showed a significant reduction in urinary oxalates.


Metabolic features and renal outcomes of urolithiasis in children
It is suggested that school-age children with renal colic and pre-school- age children with UTI should be evaluated for urolithiasis and the evaluation for metabolic risk factors is important in order to prevent recurrence and renal insufficiency.
How should patients with cystine stone disease be evaluated and treated in the twenty-first century?
Cystinuric patients should be managed in dedicated centres offering the complete range of minimal invasive treatment modalities, enabling a personalized treatment approach in order to reduce risk and morbidity of multiple procedures.
[Cystinic nephrolythiasis: clinical experience and new diagnostic and therapeutic perspectives].
Clinical manifestations of cystinuria are essentially those related to stones formation and their movement across the urinary tract, like flank pain/abdomen pain and hematuria, as occurred in other nephrolithiasis types.
Update on cystinuria
With several recent advances in the monitoring and treatment of cystinuria, and the gathering of clinical patient data, there are now opportunities for new management protocols and therapies.
Multimodal Treatments of Cystine Stones: An Observational, Retrospective Single-Center Analysis of 14 Cases
Patients with cystine stones have high recurrence or regrowth rates and relatively large stone burdens, andequate treatment schedules must be established in these cases to prevent possible deterioration of renal function.
Ethnobotanical Study of Medicinal Plants of Hezar Mountain Allocated in South East of Iran
The traditional uses of 92 species belonging to 35 vascular plant families and 78 genera have been recorded, the largest number of medicinal species came from Lamiaceae (15.2%) and the most common preparations were decoction and infusion.
Botanical medicines for the urinary tract
The antinephrotoxic botanicals Rheumpalmatum (Chinese rhubarb) root and Lespedezacapitata (round-head lespedeza) herb are surveyed, followed by herbs for symptoms of benign prostatic hyperplasia, most notably Serenoarepens (saw palmetto) fruit, Urticadioica root, and Prunusafricana (pygeum) bark.
Kidney stones: an update on current pharmacological management and future directions
The effect of medical expulsive therapy on spontaneous stone passage, pharmacotherapy in the prevention of stone recurrence, and future directions in the treatment of kidney stone disease are discussed.
Results of 5,035 stone analyses: a contribution to epidemiology of urinary stone disease.
Between 1978 and 1988 5,035 urinary calculi have been analysed by X-ray diffractometry and 1,615 of these stones have additionally been investigated by scanning electron microscopy, finding the recurrence rate of brushite stones amounting to 66.7% is very high and exceeds even that of cystine stones (60.7%).
Cystine calculi: challenging group of stones
The role of medical management and minimally invasive surgery was reviewed for the treatment of cystinuria and development of urinary tract cystine calculi is the only clinical manifestation of this disease.